Obese Pre-dabetic. Impaired glucose tolerance (oral)
Conditions
Interventions
Intervention 1: The control group will receive placebo (the same as saffron pill in doses of 15mg)once a day for 8 weeks. Intervention 2: The intervention group will receive saffron pill in dosage 15
Placebo
Treatment - Drugs
The control group will receive placebo (the same as saffron pill in doses of 15mg)once a day for 8 weeks
The intervention group will receive saffron pill in dosage 15 mg ,once a day (for 8 weeks)
Sponsors
Yazd University of Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: all patients which are defined as pre-diabetes who referring to the Imam Ali nutrition clinic all patients with BMI greater than 25 who referring to the Imam Ali nutrition clinic
Exclusion criteria
Exclusion criteria: Pregnancy change in diet or physical activity change in dosage change in type of drug Lack of interest in cooperation having other diseases in during the study Do not use more than 30% pills
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| LDL (lipid profile index). Timepoint: Before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;TG (lipid profile index). Timepoint: Before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;Cholesterol(lipid profile index). Timepoint: Before and after intervention. Method of measurement: Standards of medical diagnostic laboratories. | — |
Secondary
| Measure | Time frame |
|---|---|
| Triglyceride, , LDL-Chol, BUN, Creatinine, DPPH. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;Cholesterol. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;LDL cholesterol concentration. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;BUN. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;Creatinine. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories.;DPPH. Timepoint: before and after intervention. Method of measurement: Standards of medical diagnostic laboratories. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr.Azadeh Nadjarzadeh
shahid sadoughi university of medical sciences
Outcome results
None listed